Alterations identified by Titan-CNA in the 4q12 MCR covered recognized oncogenes and genes with known biological significance in glioma and glioblastoma, including PDGFRA, REST, and CLOCK9,23,24 (Figure 2F box). The gene discussed is PDGFRA; the disease is central nervous system cancer.